South Africa

BMI View: The South African government's move to limit market exclusivity periods on patented medicines will be positive for the local economy. It will drive domestic production of... 2013-04-25

BMI View: In light of swifter global uptake of generic medicines and heightened competition in the generic drug sector, acquisitions will become more popular as a growth strategy for... 2013-04-19

BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market. The country currently boasts the largest medicines market... 2013-04-02

BMI View: Internal disruptions to the company's senior management panel, in addition to poor cost- and expense-containment capabilities, are making Cipla Medpro increasingly susceptible... 2013-03-28

BMI View: We maintain our view that Aspen's acquisition of Sigma Pharmaceuticals will see the company tapping into the wider South East Asian region, and this expansion will be a key... 2013-03-11

BMI View: In line with its overall growth strategy and increasing competition in the local market, in addition to generating stagnant 2012 quarterly revenues in India, key player Cipla... 2013-03-04

BMI View: Because South Africa's HIV/AIDS prevalence occurs primarily among low-income earners in the country's rural settlements, Mylan (Proprietary) Limited will need to strategically... 2013-02-27